Search
for
Sort by
Research 61–90 of 1000+
- Ritlecitinib Efficacy in Adolescents With Alopecia Areata: A Real‐World Experience
- Increased Incidence and Risk of Hair Loss with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Multicentre Cohort Study
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- The Ecology of Human Sleep (EcoSleep) Project: Protocol for a longitudinal cohort repeated-measurement-burst study to assess the relationship between sleep determinants and sleep outcomes under real-world conditions across time of year
- Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database
- Deucravacitinib in dermatology: current indication and existing off-label data
- Disproportionality analysis comparing safety profiles of sonidegib and vismodegib based on the FAERS database
- A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
- AI03 Steps towards safely deploying the world’s first autonomous artificial intelligence as a medical device for skin cancer into a National Health Service teledermatology pathway
- Trichoscopy and Computational Models for Hair and Scalp Disorders: Image Analysis, Quantification, and Clinical Integration
- Use of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics
- Machine Learning--Enhanced Pharmacovigilance Assessment of Cardiac Adverse Events Associated With Minoxidil
- Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events
- Shedding light on therapeutics in alopecia and their relevance to COVID-19
- “From evidence to practice” – Insights from the multidisciplinary team on the optimal integration of GLP‐1 receptor agonists in obesity management services
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care
- Scalp Disease Detection Using Deep Learning: A Hybrid Ensemble Approach with EfficientNetB0, DenseNet121 and MobileNetV2
- Postmarketing Surveillance of New Antiepileptic Drugs: The Tribulations of Trials
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Prescribing patterns amongst UK dermatologists for the treatment of alopecia areata, female pattern hair loss, and frontal fibrosing alopecia
- Scientific Validation of "Clinically Proven" Claims: Compliance Focused and Global Regulatory Insights
- A Fuzzy Logic-Based Computational Framework for Precision Triage in Androgenetic Alopecia: A Simulated Biomarker-Driven Approach
- Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches
- Upadacitinib for Alopecia: Current Evidence and Clinical Insights
- The patient journey in prurigo nodularis: what lies ahead